Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.77 Million ≈ $6.41 Million USD) by net assets (CN¥2.26 Billion ≈ $330.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688505 net asset quality index to measure how much of total assets are equity-financed.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 688505 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dor Alon TA:DRAL	0.005x
Carasso TA:CRSO	0.003x
Macmic Science & Technology Co Ltd SHG:688711	0.040x
Prashkovsky TA:PRSK	-0.008x
JK Paper Limited NSE:JKPAPER	0.088x
Replimune Group Inc NASDAQ:REPL	-0.313x
Zhejiang Tongxing Technology Co. Ltd. A SHE:301252	N/A
KSL Holdings Bhd KLSE:5038	-0.025x

Annual Cash Flow Conversion Efficiency for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Fudan-Zhangjiang Bio-Pharmaceut.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.12 Billion ≈ $309.74 Million	CN¥141.40 Million ≈ $20.69 Million	0.067x	+1142.58%
2024-12-31	CN¥2.31 Billion ≈ $337.33 Million	CN¥-14.77 Million ≈ $-2.16 Million	-0.006x	-121.28%
2023-12-31	CN¥2.36 Billion ≈ $345.13 Million	CN¥71.02 Million ≈ $10.39 Million	0.030x	-58.95%
2022-12-31	CN¥2.25 Billion ≈ $329.69 Million	CN¥165.27 Million ≈ $24.18 Million	0.073x	-40.27%
2021-12-31	CN¥2.19 Billion ≈ $320.41 Million	CN¥268.90 Million ≈ $39.35 Million	0.123x	+118.28%
2020-12-31	CN¥2.01 Billion ≈ $293.91 Million	CN¥113.00 Million ≈ $16.54 Million	0.056x	-80.50%
2019-12-31	CN¥933.15 Million ≈ $136.55 Million	CN¥269.23 Million ≈ $39.40 Million	0.289x	+64.76%
2018-12-31	CN¥993.28 Million ≈ $145.35 Million	CN¥173.94 Million ≈ $25.45 Million	0.175x	+265.92%
2017-12-31	CN¥892.48 Million ≈ $130.60 Million	CN¥42.71 Million ≈ $6.25 Million	0.048x	-70.28%
2016-12-31	CN¥873.05 Million ≈ $127.76 Million	CN¥140.57 Million ≈ $20.57 Million	0.161x	+28.05%
2015-12-31	CN¥765.84 Million ≈ $112.07 Million	CN¥96.30 Million ≈ $14.09 Million	0.126x	-3.74%
2014-12-31	CN¥676.42 Million ≈ $98.98 Million	CN¥88.36 Million ≈ $12.93 Million	0.131x	-17.35%
2013-12-31	CN¥565.92 Million ≈ $82.81 Million	CN¥89.44 Million ≈ $13.09 Million	0.158x	-62.69%
2012-12-31	CN¥260.11 Million ≈ $38.06 Million	CN¥110.19 Million ≈ $16.12 Million	0.424x	+71.76%
2011-12-31	CN¥201.07 Million ≈ $29.42 Million	CN¥49.59 Million ≈ $7.26 Million	0.247x	+685.36%
2010-12-31	CN¥168.71 Million ≈ $24.69 Million	CN¥-7.11 Million ≈ $-1.04 Million	-0.042x	-191.84%
2009-12-31	CN¥168.37 Million ≈ $24.64 Million	CN¥7.72 Million ≈ $1.13 Million	0.046x	+121.91%
2008-12-31	CN¥75.88 Million ≈ $11.10 Million	CN¥-15.89 Million ≈ $-2.33 Million	-0.209x	+13.44%
2007-12-31	CN¥71.04 Million ≈ $10.40 Million	CN¥-17.18 Million ≈ $-2.51 Million	-0.242x	-14.96%
2006-12-31	CN¥101.70 Million ≈ $14.88 Million	CN¥-21.40 Million ≈ $-3.13 Million	-0.210x	--

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

SHG:688505 China Drug Manufacturers - Specialty & Generic

Market Cap

$763.30 Million

CN¥5.22 Billion CNY

Market Cap Rank

#10093 Global

#2645 in China

Share Price

CN¥7.42

Change (1 day)

-1.07%

52-Week Range

CN¥6.68 - CN¥10.74

All Time High

CN¥39.80